4.7 Review

Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 81, 期 -, 页码 75-93

出版社

ELSEVIER
DOI: 10.1016/j.addr.2014.09.001

关键词

Circulating miRNAs; Cancer diagnosis; Prognosis; Biomarkers; Cancer therapy

资金

  1. National Natural Science Foundation of China [30901068, 31472187]
  2. Science and Technology Commission of Shanghai Municipality of China [10410703400, 10PJ1412300]

向作者/读者索取更多资源

MicroRNAs (miRNAs) belong to a class of small non-coding RNAs that regulate numerous biological processes by targeting a broad set of messenger RNAs. Recently, miRNAs have been detected in remarkably stable forms in many types of body fluids. A comparison between cancer patients and healthy individuals has clearly shown that certain types of circulating miRNAs are associated with cancer initiation and progression. Research on miRNA-based biomarkers has witnessed phenomenal growth, owing to the non-invasive nature of miRNA-based screening assays and their sensitivity and specificity in detecting cancers. Consequently, a considerable effort has been devoted to identify suitable miRNAs for cancer diagnosis and also decode the information carried by circulating miRNAs. This review highlights the current studies that focus on the identification of circulating miRNA-based diagnostic and prognostic markers, for the most prevalent types of cancer. Additionally, the review also provides an insight into the putative functions of miRNAs, and attempts to delineate the mechanisms through which they are released into the bloodstream. Moreover, methodologies and strategies for identification of circulating miRNAs in cancers are summarized. Finally, potential strategies for circulating miRNA-based cancer therapies are proposed. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据